Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07634939 · ClinicalTrials.gov registry record
Liver Micro Flow - MRI
A clinical trial, sponsored by University of Wisconsin, Madison.
- Not yet
- Registry status
- 110
- Enrollment target
NCT07634939: Clinical Trial study, sponsored by University of Wisconsin, Madison.
NCT07634939 is a clinical trial that has not yet begun recruiting, run by University of Wisconsin, Madison. The registered enrollment target is 110 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07634939 has not yet begun recruiting, sponsored by University of Wisconsin, Madison.
- NOT YET RECRUITING
- Registry status
- 110 participants
- Enrollment target
Study Summary
This study integrates and evaluates a series of novel MRI methods for quantifying blood perfusion and tissue microstructure. The proposed perfusion and microstructure measures may provide biomarkers for fibrosis, cirrhosis, portal hypertension, and response to treatment. The precision of these methods will be evaluated in 110 participants, including healthy volunteers, people with chronic liver disease (CLD), and people with liver fibrosis.
Primary Outcome
Test-retest repeatability of IVIM parameters will be acquired during a single study visit, summarized using repeatability coefficients and Bland-Altman analysis.
Interventions
- DEVICE Novel MRI Software
- OTHER Ensure Plus Nutrition Shake
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2026-07-01 |
| Est. Completion | 2029-05 |
What is known before NCT07634939 opens enrollment
NCT07634939 is an observational study that tracks outcomes without assigning an intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Novel MRI Software is the first listed.
NCT07634939 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07634939 about?
NCT07634939 is a clinical study titled "Liver Micro Flow - MRI". This study integrates and evaluates a series of novel MRI methods for quantifying blood perfusion and tissue microstructure. The proposed perfusion and microstructure measures may provide biomarkers for fibrosis, cirrhosis, portal hypertension, and response to treatment. The precision of these metho...
What is the current status of trial NCT07634939?
This trial is currently not yet recruiting. The enrollment target is 110 participants. The study started on 2026-07-01. Estimated completion is 2029-05.
What interventions are being tested in trial NCT07634939?
The interventions under investigation include: Novel MRI Software (DEVICE), Ensure Plus Nutrition Shake (OTHER).
Who is sponsoring clinical trial NCT07634939?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01530373 · 110 participants · Phase 2
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
- NCT02379377 · 110 participants · Phase 1
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
- NCT02411773 · 110 participants · Phase 1
Sympatholysis in Chronic Kidney Disease
- NCT03190941 · 110 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI